HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Richard F Kefford Selected Research

Formaldehyde (Formol)

1/2019Distinct Molecular Profiles and Immunotherapy Treatment Outcomes of V600E and V600K BRAF-Mutant Melanoma.
4/2014Concordant BRAFV600E mutation status in primary melanomas and associated naevi: implications for mutation testing of primary melanomas.
1/2013Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Richard F Kefford Research Topics

Disease

97Melanoma (Melanoma, Malignant)
01/2023 - 03/2003
44Neoplasms (Cancer)
11/2020 - 02/2003
14Neoplasm Metastasis (Metastasis)
01/2023 - 07/2012
10Disease Progression
12/2015 - 06/2007
6Brain Neoplasms (Brain Tumor)
01/2021 - 05/2012
3Nevus (Nevi)
11/2011 - 08/2009
3Pancreatic Neoplasms (Pancreatic Cancer)
07/2007 - 10/2006
2Uveal melanoma
11/2018 - 10/2006
2Fever (Fevers)
10/2014 - 11/2012
2Nervous System Neoplasms (Neoplasms, Nervous System)
07/2007 - 12/2006
1Monosomy
11/2018
1Hemolysis
04/2016
1Autoimmune Hemolytic Anemia (Cold Agglutinin Disease)
04/2016
1Adenocarcinoma
04/2015
1Arthritis (Polyarthritis)
01/2015
1Tenosynovitis
01/2015
1Sarcoma (Soft Tissue Sarcoma)
10/2014
1Acneiform Eruptions
10/2014
1Squamous Cell Carcinoma (Epidermoid Carcinoma)
10/2014
1Keratosis
10/2014
1Facial Paralysis (Facial Palsy)
04/2013
1Carcinogenesis
12/2012
1Neutropenia
11/2012

Drug/Important Bio-Agent (IBA)

22dabrafenibIBA
01/2019 - 03/2012
16Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2017 - 07/2012
13trametinibIBA
01/2020 - 11/2012
9Immune Checkpoint InhibitorsIBA
01/2023 - 08/2015
9Biomarkers (Surrogate Marker)IBA
01/2020 - 05/2012
9VemurafenibIBA
12/2015 - 03/2012
9Tumor Suppressor Protein p14ARF (p14ARF)IBA
02/2010 - 02/2003
8Proteins (Proteins, Gene)FDA Link
01/2018 - 02/2009
7DNA (Deoxyribonucleic Acid)IBA
08/2020 - 03/2003
6Phosphotransferases (Kinase)IBA
01/2020 - 12/2014
6Cyclin-Dependent Kinase Inhibitor p16IBA
11/2011 - 10/2008
5Circulating Tumor DNAIBA
08/2020 - 01/2018
5Mitogen-Activated Protein KinasesIBA
01/2020 - 07/2013
5AntibodiesIBA
01/2018 - 07/2012
3CytokinesIBA
01/2023 - 03/2014
3ParaffinIBA
01/2019 - 01/2013
3Formaldehyde (Formol)FDA Link
01/2019 - 01/2013
3NivolumabIBA
09/2017 - 04/2016
3pembrolizumabIBA
09/2017 - 01/2015
3Type 1 Melanocortin ReceptorIBA
09/2013 - 03/2003
2Cell-Free Nucleic AcidsIBA
08/2020 - 09/2013
2RNA (Ribonucleic Acid)IBA
01/2020 - 01/2018
2InterferonsIBA
01/2018 - 03/2017
2IpilimumabIBA
01/2018 - 04/2016
2CateninsIBA
10/2017 - 01/2014
2L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
03/2016 - 03/2010
2Cyclin-Dependent Kinases (cdk Proteins)IBA
03/2013 - 11/2005
2Tumor Suppressor Proteins (Proteins, Tumor Suppressor)IBA
08/2009 - 07/2007
1Histocompatibility Antigens Class IIBA
11/2020
1AntigensIBA
11/2020
1Immune Checkpoint ProteinsIBA
01/2020
1Dual Specificity Phosphatase 6IBA
01/2019
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
11/2018
1RNA Splicing FactorsIBA
11/2018
1Peptide Initiation Factors (Initiation Factor)IBA
11/2018
1Programmed Cell Death 1 ReceptorIBA
01/2018
1Tumor Biomarkers (Tumor Markers)IBA
01/2018
1encorafenibIBA
09/2017
1Blood Proteins (Serum Proteins)IBA
01/2017
1Monoclonal AntibodiesIBA
04/2016
1IsoantibodiesIBA
04/2016
1tributyl phosphate (TBP)IBA
10/2014
1Adrenal Cortex Hormones (Corticosteroids)IBA
10/2014
1SteroidsIBA
10/2014
1Acetaminophen (Paracetamol)FDA LinkGeneric
10/2014
1Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA
10/2014
1Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
09/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2014
1ChemokinesIBA
03/2014
1nilotinibFDA Link
07/2013
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
07/2013
1Imatinib Mesylate (Gleevec)FDA Link
07/2013
1Proto-Oncogene Proteins c-kit (Proto-Oncogene Protein c-kit)IBA
07/2013
1Cadherins (E-Cadherin)IBA
05/2013
1A-Form DNA (A-DNA)IBA
03/2013
1thiamine triphosphorate (TTP)IBA
01/2013
1Lipase (Acid Lipase)FDA Link
11/2012
1AmylasesFDA Link
11/2012
1Proto-Oncogene Proteins B-rafIBA
07/2012
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
03/2012
1Granzymes (Granzyme)IBA
03/2012
1PLX 4720IBA
03/2012
1Microphthalmia-Associated Transcription FactorIBA
11/2011
1CI 22IBA
04/2011
1Dacarbazine (DIC)FDA LinkGeneric
03/2010
1Bosentan (Tracleer)FDA Link
03/2010
1Endothelin Receptor AntagonistsIBA
03/2010
1Endothelins (Endothelin)IBA
03/2010
1interleukin-21 (interleukin 21)IBA
03/2009

Therapy/Procedure

34Therapeutics
01/2023 - 02/2005
10Immunotherapy
01/2023 - 03/2010
4Drug Therapy (Chemotherapy)
01/2021 - 06/2007
2Aftercare (After-Treatment)
10/2014 - 03/2012
1Radiotherapy
01/2021
1Neoadjuvant Therapy
01/2019
1Drug Tapering
10/2014
1Precision Medicine
12/2012